On the other hand, hyperglycemic hyperosmolarity syndrome (HHS) develops in type 2 diabetic patients who still have some degree of insulin secretory ability due to infections, non-compliance with treatment, drugs, or coexisting diseases (endocrine diseases, cancer, etc.), and is often accompanied by ketosis. This evidence concerns the gene INS and hypotrichosis 1.